Currently out of the existing stock ratings of Prakhar Agrawal, 33 are a BUY (91.67%), 3 are a HOLD (8.33%).

Prakhar Agrawal

Work Performance Price Targets & Ratings Chart

Analyst Prakhar Agrawal, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 34.07% that have a potential upside of 37.68% achieved within 78 days.

Prakhar Agrawal’s has documented 68 price targets and ratings displayed on 13 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MLTX, MoonLake Immunotherapeutics at 23-Sep-2024.

Wall Street Analyst Prakhar Agrawal

Analyst best performing recommendations are on NEXI (NEXIMMUNE).
The best stock recommendation documented was for DICE (DICE MOLECULES HOLDINGS LLC) at 9/14/2022. The price target of $36 was fulfilled within 27 days with a profit of $16.39 (83.58%) receiving and performance score of 30.96.

Average potential price target upside

ARNA Arena Pharmaceuticals LABP Landos Biopharma PHAT Phathom Pharmaceuticals OCUP Ocuphire Pharma EQ Equillium MLTX MoonLake Immunotherapeutics TGTX TG Therapeutics NEXI Neximmune PRVB Provention Bio DICE Dice Molecules Holdings LLC AKRO Akero Therapeutics CBAY Cymabay Therapeu RAPT RAPT Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$100

$0.01 (0.01%)

$120

2 years 9 months 8 days ago
(09-Feb-2022)

3/5 (60%)

$6.56 (7.02%)

256

Hold

$100

2 years 10 months 21 days ago
(27-Dec-2021)

4/6 (66.67%)

$9.27 (10.22%)

204

Hold

$100

$0.01 (0.01%)

$102

2 years 11 months 2 days ago
(15-Dec-2021)

4/6 (66.67%)

$7.15 (7.70%)

247

Hold

$79

2 years 11 months 2 days ago
(15-Dec-2021)

5/5 (100%)

$33.14 (72.26%)

401

Hold

$100

$0.01 (0.01%)

2 years 11 months 2 days ago
(15-Dec-2021)

3/4 (75%)

$7.15 (7.70%)

557

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Prakhar Agrawal is most bullish on?

Potential upside of $0 has been obtained for AKRO (AKERO THERAPEUTICS)

Which stock is Prakhar Agrawal is most reserved on?

Potential downside of -$0 has been obtained for MLTX (MOONLAKE IMMUNOTHERAPEUTICS)

What Year was the first public recommendation made by Prakhar Agrawal?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?